The Coeur Scientific Inc. team has 100 years of combined laboratory experience conducting innovative, specialized preclinical studies evaluating membrane oxygenators, artificial hearts, intra-aortic balloons, pulmonary respirators, tissue adhesives, orthopaedic devices and many surgical procedures.  Pharmacological studies have been performed on oral contraceptives, anti-neoplastic agents, anti-inflammatory agents and compounds addressing cardiovascular and kidney diseases.  Models for proof-of-concept evaluations or human clinical conditions can be developed as needed.  Our experience allows us to offer customized studies to meet your specific needs.
 

Coeur offers documentation in compliance with FDA GLP regulations.  We are experienced in protocol preparations for IACUC and IRB submissions and have assisted in the evaluation of scores of Class II and Class III devices.  Our facilities meet all of the requirements of the federal and state laws pertaining to laboratory models under the AWA as enforced by the USDA, and our protocols are inspected by the FDA, EPA, USDA, and equivalent European and Japanese regulatory agencies.  Our in vivo facilities are AAALAC International accredited.
 

Through Coeur‘s association with medical centers, research institutes, research and development companies and universities in Northern California, we offer our clients unique opportunities to have their products evaluated in preclinical settings by researchers active in clinical care.  This provides an excellent opportunity to make a rapid transition from the preclinical laboratory to clinical trials.  The practice of new surgical techniques can be performed in training sessions developed and conducted by our staff.